XINYUAN REAL ESTATE CO L-ADR (XIN) Stock Fundamental Analysis

NYSE:XIN • US98417P2048

1.95 USD
-0.02 (-1.02%)
Last: Sep 3, 2025, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to XIN. XIN was compared to 63 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of XIN have multiple concerns. XIN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • XIN had negative earnings in the past year.
  • XIN had a positive operating cash flow in the past year.
  • In the past 5 years XIN reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: XIN reported negative operating cash flow in multiple years.
XIN Yearly Net Income VS EBIT VS OCF VS FCFXIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.01%, XIN is in line with its industry, outperforming 53.97% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 2.42%, XIN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -1.01%
ROE N/A
ROIC 2.42%
ROA(3y)-1.59%
ROA(5y)-2.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XIN Yearly ROA, ROE, ROICXIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

  • XIN has a Operating Margin of 7.63%. This is in the better half of the industry: XIN outperforms 73.02% of its industry peers.
  • XIN's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 16.12%, XIN is in line with its industry, outperforming 41.27% of the companies in the same industry.
  • XIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.63%
PM (TTM) N/A
GM 16.12%
OM growth 3YN/A
OM growth 5Y-9.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y53.91%
GM growth 5Y-6.51%
XIN Yearly Profit, Operating, Gross MarginsXIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • XIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for XIN has been reduced compared to 1 year ago.
  • Compared to 5 years ago, XIN has more shares outstanding
  • XIN has a better debt/assets ratio than last year.
XIN Yearly Shares OutstandingXIN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
XIN Yearly Total Debt VS Total AssetsXIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • XIN has an Altman-Z score of 0.10. This is a bad value and indicates that XIN is not financially healthy and even has some risk of bankruptcy.
  • XIN has a Altman-Z score of 0.10. This is in the lower half of the industry: XIN underperforms 68.25% of its industry peers.
  • The Debt to FCF ratio of XIN is 103.68, which is on the high side as it means it would take XIN, 103.68 years of fcf income to pay off all of its debts.
  • XIN has a Debt to FCF ratio (103.68) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 103.68
Altman-Z 0.1
ROIC/WACC1.49
WACC1.63%
XIN Yearly LT Debt VS Equity VS FCFXIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

  • XIN has a Current Ratio of 1.12. This is a normal value and indicates that XIN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.12, XIN is not doing good in the industry: 65.08% of the companies in the same industry are doing better.
  • XIN has a Quick Ratio of 1.12. This is a bad value and indicates that XIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • XIN's Quick ratio of 0.27 is on the low side compared to the rest of the industry. XIN is outperformed by 84.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.27
XIN Yearly Current Assets VS Current LiabilitesXIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • XIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -215.38%.
  • Looking at the last year, XIN shows a very negative growth in Revenue. The Revenue has decreased by -36.04% in the last year.
  • XIN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -26.99% yearly.
EPS 1Y (TTM)-215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.33%
Revenue 1Y (TTM)-36.04%
Revenue growth 3Y-30.53%
Revenue growth 5Y-26.99%
Sales Q2Q%-13.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XIN Yearly Revenue VS EstimatesXIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XIN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XIN Price Earnings VS Forward Price EarningsXIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of XIN indicates a rather cheap valuation: XIN is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.77
EV/EBITDA N/A
XIN Per share dataXIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for XIN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

XINYUAN REAL ESTATE CO L-ADR

NYSE:XIN (9/3/2025, 8:04:00 PM)

1.95

-0.02 (-1.02%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)12-13
Inst Owners0.42%
Inst Owner Change-9.09%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.49M
Revenue(TTM)515.00M
Net Income(TTM)-50.83M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)-57.09%
DP-6.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 0.77
P/OCF 0.75
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.52
FCFY129.07%
OCF(TTM)2.6
OCFY133.44%
SpS74.45
BVpS-15.18
TBVpS-15.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.01%
ROE N/A
ROCE 3.22%
ROIC 2.42%
ROICexc 2.42%
ROICexgc 2.42%
OM 7.63%
PM (TTM) N/A
GM 16.12%
FCFM 3.38%
ROA(3y)-1.59%
ROA(5y)-2.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-26.22%
ROICexc growth 3YN/A
ROICexc growth 5Y-26.22%
OM growth 3YN/A
OM growth 5Y-9.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y53.91%
GM growth 5Y-6.51%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 103.68
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.11%
Interest Coverage 1.03
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.27
Altman-Z 0.1
F-Score3
WACC1.63%
ROIC/WACC1.49
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.04%
Revenue growth 3Y-30.53%
Revenue growth 5Y-26.99%
Sales Q2Q%-13.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.4%
EBIT growth 3YN/A
EBIT growth 5Y-33.94%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.42%
FCF growth 3Y-49.29%
FCF growth 5Y-42.07%
OCF growth 1Y106.64%
OCF growth 3Y-48.99%
OCF growth 5Y-41.92%

XINYUAN REAL ESTATE CO L-ADR / XIN FAQ

What is the ChartMill fundamental rating of XINYUAN REAL ESTATE CO L-ADR (XIN) stock?

ChartMill assigns a fundamental rating of 1 / 10 to XIN.


Can you provide the valuation status for XINYUAN REAL ESTATE CO L-ADR?

ChartMill assigns a valuation rating of 2 / 10 to XINYUAN REAL ESTATE CO L-ADR (XIN). This can be considered as Overvalued.


What is the profitability of XIN stock?

XINYUAN REAL ESTATE CO L-ADR (XIN) has a profitability rating of 2 / 10.


How financially healthy is XINYUAN REAL ESTATE CO L-ADR?

The financial health rating of XINYUAN REAL ESTATE CO L-ADR (XIN) is 2 / 10.


How sustainable is the dividend of XINYUAN REAL ESTATE CO L-ADR (XIN) stock?

The dividend rating of XINYUAN REAL ESTATE CO L-ADR (XIN) is 0 / 10 and the dividend payout ratio is -6.67%.